MindWalk Stock Comparisons Highlight Analyst Upside

5 sourcesUpdated Oct 11, 20261 min read

0

Sponsored

Four stock-comparison reports assess MindWalk against Mettler-Toledo, Fortrea and Ginkgo Bioworks across analyst ratings, valuation, risk, profitability and ownership. The reports generally cite MindWalk’s higher analyst-rated upside and lower share-price volatility than those peers, while noting its institutional ownership is low at 6.7%. Fortrea is described as having lower revenue but higher earnings than MindWalk and a lower price-to-earnings ratio; Mettler-Toledo leads MindWalk on 10 of 15 comparison measures, while MindWalk leads Fortrea on nine and Ginkgo on eight. MindWalk says it uses its HYFT Technology, LensAI and ReefIQ platforms to discover and develop biologics and AI-enabled drug discovery.

Sponsored

In this story:

More on this story

Back to News

Finance

Money Concepts Invests $133 Million Across Five ETFs

Money Concepts Capital Corp disclosed new third-quarter positions across five ETFs, spanning small-cap value, semiconductors, long-term bonds, dividends and buybacks, and managed futures. Its largest reported purchases were 1.6 million shares of the small-cap value and managed-futures funds, valued at about $68 million and $50 million, respectively.

38 sources

Business

SEBI clears IPO plans for Razorpay, Sembcorp Green Infra and MakeMyTrip India

SEBI has cleared IPO plans for Razorpay, Sembcorp Green Infra and MakeMyTrip India, allowing the companies to advance preparations for public offerings. Razorpay’s issue could raise ₹5,000–6,000 crore, while Sembcorp has proposed a fresh issue of up to ₹3,750 crore.

4

Total sources5

Last updatedOct 11, 2026

Does this breakdown look right?

Sponsored

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

6 sources

Sponsored

Business

Anthropic IPO Valuation Could Reach $1.5 Trillion

Anthropic’s planned IPO is facing mounting uncertainty as investors reportedly push to lower its expected valuation from roughly $1.4 trillion–$1.5 trillion, with estimates ranging toward $1 trillion to $1.3 trillion amid a sell-off in AI stocks. Prediction-market odds for a near-term listing have also fallen, and reports say the company could reduce the offering or delay it.

499 sources